Evangelia Vlachou, MD

Evangelia Vlachou, MD, a postdoctoral research fellow at Johns Hopkins Medicine.

Articles by Evangelia Vlachou, MD

Screenshot of an interview with Evangelia Vlachou, MD

Enfortumab Vedotin With or Without Pembrolizumab Delivers Promising Responses for Upper Tract Urothelial Cancer

February 14th 2025

Enfortumab vedotin with or without pembrolizumab offers disease control benefits for patients with upper tract urothelial cancer, said Evangelia Vlachou, MD, of Johns Hopkins Medicine.

Evangelia Vlachou, MD

Articles by Evangelia Vlachou, MD

Enfortumab Vedotin With or Without Pembrolizumab Delivers Promising Responses for Upper Tract Urothelial Cancer

Latest Updated Articles

Trending on AJMC

Cytokines Linked With Drug Resistance in Ovarian Cancer, but Underlying Mechanisms Remain Unclear

Mepolizumab Reduces Health Care Resource Utilization, Work Impairment in Severe Asthma

CHEST 2025 Highlights: Future of Respiratory Vaccines and the Impact of Federal Funding Cuts

Elinzanetant Shows Consistent Efficacy, Safety, and Sleep Benefits Across Studies

Digital, Blood-Based Innovations Transform Alzheimer Disease Detection: Ken Cohen, MD, FACP